Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.
about
Bordetella pertussis isolates in Finland: serotype and fimbrial expressionShifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programsUse of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods.Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genesAdenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice.Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussisAdhesion of Bordetella pertussis to eukaryotic cells requires a time-dependent export and maturation of filamentous hemagglutininProduction of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals.Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussisLethal infection by Bordetella pertussis mutants in the infant mouse model.Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells.Fimbriae and determination of host species specificity of Bordetella bronchiseptica.Effects of guanidinium hydrochloride on the structure and immunological properties of Bordetella pertussis fimbriaeFimbrial typing of Bordetello pertussis isolates: agglutination with polyclonal and monoclonal antisera.Fimbrial typing of Bordetella pertussis isolates: agglutination with polyclonal and monoclonal antibodies.
P2860
Q33371827-675DBF87-ED7F-489B-9BF4-5661E90EB470Q33856133-D190CF96-9D2B-4A75-8124-AFF5A185E937Q33859230-F485C5A7-1981-4D28-82B2-411BA839EA21Q35101601-4AEF2426-4EE8-40AB-B578-A73D44CBD048Q35106655-1EECBF08-AF56-48D7-9B41-B19724FEDF38Q35775578-FE41EC2A-95EC-4C09-A706-65DB5593BB16Q36578698-889E46AB-3FE0-441A-9880-3395DAC8F407Q36963362-9F278417-AB17-4AD4-B316-E95EA3F65BC4Q37002319-36703C4C-AE53-40ED-A93E-041ED15E68ECQ37006917-990C5A3B-84C0-476C-BC02-93F7AB4A6566Q37367187-0006FDFC-73D2-4D7E-B813-8126307147ADQ40188154-9429D21A-2138-48C4-860F-C0F6976599A8Q42214426-A9F669B6-5376-4AFF-996B-4A23EDE6B13AQ42727503-3FE48F90-EE64-4297-BBD8-771BD012232FQ42727959-4B6BB18A-CC8E-4104-B32A-8332323C5862
P2860
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Comparison of type 2 and type ...... inating monoclonal antibodies.
@en
type
label
Comparison of type 2 and type ...... inating monoclonal antibodies.
@en
prefLabel
Comparison of type 2 and type ...... inating monoclonal antibodies.
@en
P2093
P2860
P1476
Comparison of type 2 and type ...... inating monoclonal antibodies.
@en
P2093
P2860
P304
P407
P577
1988-12-01T00:00:00Z